NIH-funded research U01 cooperative agreement

IV ketamine vs morphine for acute pain in children

Official title: Efficacy of intravenous sub-dissociative ketamine versus intravenous morphine in children with acute pain.

Funded at Columbia University Health Sciences · NIH-11401174 · Data updated 2026-11-12

A new comparison in kids with acute pain will test whether a low-dose IV ketamine works as well as IV morphine for pain relief and safety in the emergency department.

More Ketamine research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 5, 2024
Project endAugust 31, 2029
Funding year2026
Award (this year)$3,193,679
NIH project number5U01HD116253-03
Project IDNIH-11401174 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children and adolescents with moderate to severe acute pain presenting to the ED who are eligible for IV analgesia and do not have contraindications to ketamine or morphine.

Less likely to help

Patients with pain etiologies or medical conditions that preclude ketamine or morphine use may not benefit from this approach.

What this research studies

This U01-funded study from Columbia University will compare sub-dissociative IV ketamine to standard IV morphine to treat moderate to severe acute pain in children and adolescents. Researchers will enroll patients presenting to the emergency department and assess pain relief, safety, and potential short- and long-term benefits. The study uses rigorous clinical protocols to monitor adverse events and analgesic outcomes, aiming to provide clearer guidance on safer and effective pain management in young patients. If ketamine provides similar pain control with fewer serious side effects, it could change practice and reduce opioid exposure for children.

Why it matters

Potential benefit: If successful, children with acute pain could receive effective relief with fewer opioid-related risks, improving safety and comfort in the ED.

How similar studies have gone: Previous adult studies show sub-dissociative ketamine can provide effective analgesia with a favorable safety profile, but pediatric data are less definitive and this study seeks to extend that evidence.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Tsze, Daniel Sing-Kwong — Columbia University Health Sciences
  • Study coordinator: Tsze, Daniel Sing-Kwong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.